|
EID1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.197100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.635800E-01 |
| Normal-vs-Stage2 |
3.832800E-01 |
| Normal-vs-Stage3 |
4.976200E-04 |
| Normal-vs-Stage4 |
2.42129999999952E-05 |
| Stage1-vs-Stage2 |
6.402600E-01 |
| Stage1-vs-Stage3 |
8.606300E-04 |
| Stage1-vs-Stage4 |
4.43650000000462E-05 |
| Stage2-vs-Stage3 |
2.580400E-01 |
| Stage2-vs-Stage4 |
9.565600E-02 |
| Stage3-vs-Stage4 |
3.576400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.420060E-02 |
| Normal-vs-AfricanAmerican |
9.323800E-03 |
| Normal-vs-Asian |
1.008460E-02 |
| Caucasian-vs-AfricanAmerican |
3.482600E-01 |
| Caucasian-vs-Asian |
1.992790E-01 |
| AfricanAmerican-vs-Asian |
3.251000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.901900E-03 |
| Normal-vs-Female |
8.278300E-02 |
| Male-vs-Female |
2.636800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.158200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.070200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.019400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.300100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.619200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.070600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.724800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.145200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.033200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.400200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.409000E-01 |
| Normal-vs-Grade 2 |
8.207400E-01 |
| Normal-vs-Grade 3 |
2.063100E-03 |
| Normal-vs-Grade 4 |
1.80560000284657E-09 |
| Grade 1-vs-Grade 2 |
1.757250E-01 |
| Grade 1-vs-Grade 3 |
1.079680E-02 |
| Grade 1-vs-Grade 4 |
4.09430000000155E-05 |
| Grade 2-vs-Grade 3 |
9.604500E-04 |
| Grade 2-vs-Grade 4 |
8.87879991751106E-10 |
| Grade 3-vs-Grade 4 |
2.00459999999403E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.916200E-01 |
| Normal-vs-ccB subtype |
2.09599999999588E-05 |
| ccA subtype-vs-ccB subtype |
6.68059996211667E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.283500E-02 |
| Normal-vs-N1 |
1.632360E-02 |
| N0-vs-N1 |
3.832100E-02 |
|
|
